Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M3,131Revenue $M70.8Net Margin (%)-74.1Altman Z-Score13.4
Enterprise Value $M3,043EPS $-1.2Operating Margin %-78.7Piotroski F-Score1
P/E(ttm)--Beneish M-Score1.8Pre-tax Margin (%)-88.6Higher ROA y-yN
Price/Book55.910-y EBITDA Growth Rate %--Quick Ratio5.6Cash flow > EarningsN
Price/Sales43.75-y EBITDA Growth Rate %--Current Ratio5.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %-210.1ROA % (ttm)-27.1Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-78.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M44.1ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with ANAC

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
ANACJoel Greenblatt 2015-09-30 Sold Out -0.01%$77.84 - $152.25
($130.63)
$ 70.95-46%Sold Out0
ANACJoel Greenblatt 2015-06-30 Buy 0.01%$52.69 - $79.09
($65.44)
$ 70.958%New holding13,741
ANACFirst Eagle Investment 2013-03-31 Sold Out -0.0017%$3.15 - $6.52
($4.31)
$ 70.951546%Sold Out0
ANACFirst Eagle Investment 2012-12-31 Buy $4.6 - $6.81
($5.55)
$ 70.951178%New holding92,390
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

ANAC is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


ANAC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-19Sell20,000$95.41-25.64view
Zane LeeSVP and Chief Medical Officer 2016-01-15Sell1,466$89.57-20.79view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2016-01-04Sell855$112.28-36.81view
Sullivan Ryan TSr. VP and General Counsel 2016-01-04Sell733$111.78-36.53view
BERNS PAUL LPresident and CEO 2016-01-04Sell2,533$112.35-36.85view
Zane LeeSVP and Chief Medical Officer 2015-12-15Sell14,000$113.17-37.31view
BERNS PAUL LPresident and CEO 2015-12-11Sell20,000$117.26-39.49view
Sullivan Ryan TSr. VP and General Counsel 2015-12-10Sell10,000$110.41-35.74view
IPPOLITO VINCENT PEVP & Chief Commercial Officer 2015-12-09Sell20,000$107.9-34.24view
BERNS PAUL LPresident and CEO 2015-09-15Sell20,000$139.83-49.26view

Quarterly/Annual Reports about ANAC:

    News about ANAC:

    Articles On GuruFocus.com
    Royce Funds Comments on Anacor Pharmaceuticals Oct 12 2015 
    Staying Diversified in the Pursuit of Sustainable Growth - Royce Funds Commentary Oct 12 2015 
    Royce Smaller-Companies Growth Fund Shareholder Letter Sep 20 2015 
    Panic-Proofing the Small Investor Aug 26 2015 
    Anacor Pharmaceuticals’ Q4 Was A Solid One For Investors Mar 16 2015 
    Paulson Bets Again On Mallinckrodt Aug 07 2014 
    3 Great Dividend Stocks at All-Time Highs Aug 19 2013 
    Weekly CFO Buys Highlight Aug 19 2013 
    Senior Vice President and CFO of Anacor Pharmaceuticals Inc. Geoffrey Parker Bought 43,046 Shares Jun 20 2013 
    This Week's Top Insider Buys Jun 19 2013 

    More From Other Websites
    13G Filing: Baker Bros. Advisors and Anacor Pharmaceuticals, Inc. (ANAC) Feb 10 2016
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 05 2016
    This Trade Explains the Current Market Feb 03 2016
    6 Drug Stocks That Look to Beat the Market in 2016 Jan 18 2016
    ANACOR PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure, Other Events, Financial... Jan 11 2016
    Anacor Pharmaceuticals to Present Data From Long-Term Safety Study of Crisaborole Topical Ointment,... Jan 08 2016
    Anacor Pharmaceuticals to Present Data From Long-Term Safety Study of Crisaborole Topical Ointment,... Jan 08 2016
    [$$] Barrons.com Stock Picks Just Behind Index in '15 Jan 07 2016
    Anacor Pharmaceuticals Submits New Drug Application to the FDA for Crisaborole Topical Ointment, 2%... Jan 07 2016
    Anacor Pharmaceuticals Submits New Drug Application to the FDA for Crisaborole Topical Ointment, 2%... Jan 07 2016
    Anacor Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : December 30,... Dec 30 2015
    The Zacks Analyst Blog Highlights: ALPS Medical Breakthroughs ETF, Anacor Pharmaceuticals, Dyax,... Dec 29 2015
    The Nominees for Best Biopharma CEO of 2015 Are... Dec 15 2015
    Anacor Stayed Positive among the Hammered Mid-Caps Dec 14 2015
    Anacor Moves up on Buying Support, Leads XBI’s Mid-Cap Stocks Dec 14 2015
    3 Rising Biotechs That Should Continue Their Upward Trends Dec 12 2015
    ANACOR PHARMACEUTICALS, INC. Financials Dec 08 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK